| Client Name |
Company |
Brand |
Status |
Created On |
Data Source |
TA |
Created By |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
| Janssen |
MHNY |
Tylenol |
In-Progress |
March 21, 2022 |
CSV File |
Rare Disease |
Adriano Botter |
